If it’s part of the SAS scheme then that’s pretty public. PAR have released plenty of results themselves so bring it on.
If it’s the P2 then as Ox mentioned you wouldn’t want to breach any confidentiality if it was one of the conditions of signing up to the trial. Then again, it’s placebo controlled so maybe there is no confidentiality. Over to you.
But just the fact you talk about first hand knowledge of results - kinda indicates there are results, which is what is a result in itself.
Fifty One Capital updated report, page-28
-
- There are more pages in this discussion • 44 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
56.5¢ |
Change
-0.010(1.74%) |
Mkt cap ! $82.30M | |||
| Open | High | Low | Value | Volume |
| 58.5¢ | 60.0¢ | 54.0¢ | $780.9K | 1.372M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | 55.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 56.5¢ | 4762 | 1 |
View Market Depth
| Last trade - 10.20am 28/11/2024 (20 minute delay) ? |
| PAR (ASX) Chart |
